DISEASE INDICATIONS: Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis, Polyangiitis
MANUFACTURER: Celltrion Healthcare Hungary Kft / Teva Pharmaceuticals
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Therapeutic Goods Administration (TGA)
Truxima (rituximab) is a drug prescribed for the treatment of follicular lymphoma and diffuse large B-cell non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), severe active rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.